CD36 and metabolic dysfunction-associated steatotic liver disease: In line, disruption of hepatic CD36 protected against NAFLD-associated systemic inflammation and insulin resistance, by reducing hepatic FFA uptake and ectopic lipid deposition in HFD-fed mice (37).